SR workstation gets FDA nod

Article

Winston-Salem, NC-based PointDx is a step closer to entering the U.S. market with a structured reporting technology following the FDA clearance of its REX workstation (version 1.0). REX seamlessly integrates structured reporting with 2D and 3D image

Winston-Salem, NC-based PointDx is a step closer to entering the U.S. market with a structured reporting technology following the FDA clearance of its REX workstation (version 1.0). REX seamlessly integrates structured reporting with 2D and 3D image analysis. The technology promises to improve report turnaround time, reducing overall reporting costs and providing more concise yet comprehensive information than is possible with traditional reporting models (see feature article, this issue). Completed multimedia reports are made available instantaneously to referring physicians, who can see patient information, diagnostic findings, and images in reports delivered over a secure Internet connection. The system is designed to replicate current reporting workflow, but it automates the process to eliminate many of the inefficiencies associated with traditional reporting. Reports are accompanied by embedded images.

Recent Videos
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.